Today's News | Note: News feeds may no longer be available for the articles on this page.

Sectors for a Short-Term Rally 2:23 PM 12/29/2008
Barron's - USA
The pharmaceutical sector beat the market and has maintained its position above its 50-day moving average. ...

Salix says FDA requires additional data on bowel drug 12:13 PM 12/29/2008
Reuters - USA
Salix Pharmaceuticals Ltd said the US FDA determined that the company's balsalazide tablets application to treat ulcerative colitis in adults cannot be approved in its present form. ...

FDA approves Allergan's drug for longer eyelashes 12:39 PM 12/26/2008
Reuters - USA
Allergan Inc said that the US FDA has approved its eyelash-thickening drug Latisse for hypotrichosis of the eyelashes. ...

BioMS May Give Lilly $5 Billion Cure for Expiring Drug Patents 8:11 AM 12/26/2008
Bloomberg - USA
Eli Lilly & Co signed a $497 million licensing and development agreement for BioMS Medical Corp’s dirucotide. It has the potential to be the first marketed treatment for advanced forms of multiple sclerosis. ...

Japan Hot Stocks-Takeda Pharm gains on share cancellation 6:02 AM 12/26/2008
Forbes - NY,USA
Takeda Pharmaceutical Co Ltd said it would cancel 3.1 percent of its shares outstanding on Jan 16. Takeda is one of the top contributors to the Nikkei's rise. ...

Ferring Wins US Approval for Prostate Cancer Drug 8:19 AM 12/25/2008
Bloomberg - USA
Ferring Pharmaceuticals gained approval from the US FDA for its degarelix treatment for advanced prostate cancer. The injectable drug suppresses testosterone and lowers PSA levels associated with prostate cancer. ...

AMAG Pharma down after FDA seeks information on anemia drug 5:12 PM 12/23/2008
Forbes - NY,USA
The US FDA wants additional data to clarify a specific chemistry, manufacturing and controls (CMC) issue. There are also deficiencies in the company's manufacturing and labeling. ...

Drug Combinations Putting Seniors at Risk 2:32 PM 12/23/2008
Washington Post - United States
Almost 30 percent of seniors take at least five prescription medications. Many combine prescription and nonprescription drugs at will. ...

Teva executive upbeat on biogenerics in 2009 12:52 PM 12/23/2008
Reuters - USA
Teva Pharmaceutical Industries Ltd said that there was a "very good chance" of US legislation paving the way for generic biotechnology drugs. "Wishful thinking" also comes to mind. Congress has no regulatory pathway for generic biologics which are incredibly complex and difficult to duplicate. ...

KV Pharmaceutical Dives After Prescription Drug Shipments Halt 11:22 AM 12/23/2008
Bloomberg - USA
KV Pharmaceutical Co announced a third recall of medicines that may contain excess doses. It stopped shipping prescription tablets. It lost half its market value in New York trading. ...

Teva says Barr Pharma buyout is complete 10:52 AM 12/23/2008
Forbes - NY,USA
Teva Pharmaceutical Industries Ltd it completed its $7.5 billion buyout of Barr Pharmaceuticals Inc. It will assume $1.5 billion of Barr's debt. ...

Glaxo gets aptamer drug options in Archemix deal 8:25 AM 12/23/2008
Reuters - USA
GlaxoSmithKline has secured options to license a number of drug candidates from Archemix for inflammatory diseases. Archemix specializes in aptamer technology (protein binding). ...

Amag Fails to Receive US Approval for Anemia Drug 6:04 PM 12/22/2008
Bloomberg - USA
Amag Pharmaceuticals Inc's anemia drug ferumoxytol failed to win approval from the US FDA which is requiring the company to resolve deficiencies at its manufacturing plant. ...

Epix Pharma rockets on FDA approval for Vasovist 2:54 PM 12/22/2008
Forbes - NY,USA
The US FDA approved Epix Pharmaceuticals Inc's imaging agent Vasovist for use in the US. ...

BioCryst drug trial shows reduction in cancer cells 12:00 PM 12/22/2008
Bizjournals.com - Charlotte,NC,USA
BioCryst Pharmaceuticals reported positive clinical trial results for its experimental drug Forodesine which reduced cancer cells in some leukemia patients. ...

<- Day Earlier | Today's News